Calendar Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Market Closed - Nasdaq 04:30:00 2024-05-10 pm EDT 5-day change 1st Jan Change
0.46 USD -5.23% Intraday chart for Cadrenal Therapeutics, Inc. -6.22% -37.83%

Chart calendar Cadrenal Therapeutics, Inc.

f8e5aee4.R3jqutxYhjNI-yNnunTfy3VPQ29z7bsoMcQ3Q5YekU4.DQ3d8pIU4QQQkWsM-0ClqR8MKj4Dic1vdfBnKuRz1h80L7L-tijhSyyKRA~cbc2f386a35fdd51b4a36a04c04795fd

Upcoming events on Cadrenal Therapeutics, Inc.

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-16 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Cadrenal Therapeutics, Inc.

2024-05-09 09:00 am Q1 2024 Earnings Release
2024-04-18 01:00 pm Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-03-11 09:00 am Q4 2023 Earnings Release
2024-03-03 Technology and Heart Failure Therapeutics Conference
2024-02-01 11:00 am Lytham Partners Investor Select Conference
2023-12-04 04:00 pm Noble Capital Markets Emerging Growth Equity Conference
2023-11-08 Q3 2023 Earnings Release
2023-10-19 Annual General Meeting
2023-10-17 10:30 am Lytham Partners Fall Investor Conference - Panel
2023-10-17 07:00 am Lytham Partners Fall Investor Conference
2023-09-10 H.C. Wainwright Global Investment Conference
2023-08-10 09:00 am Q2 2023 Earnings Release
2023-06-04 BIO International Convention
2023-05-18 02:00 pm Lytham Partners Spring Investor Conference
2023-05-18 09:00 am Lytham Partners Spring Investor Conference
2023-05-10 09:00 am Q1 2023 Earnings Release
2023-02-05 BIO CEO and Investor Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


-7,63
-7,70
0.9%

-10,1

EBIT
Million USD
Released
Forecast
Spread
0,00


-7,63
-7,64
0.15%

-8,22

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-8,36
-7,64
-9.36%

-7,97

Net income
Million USD
Released
Forecast
Spread
-6,71


-8,36
-7,64
-9.36%

-7,97

EPS
USD
Released
Forecast
Spread
-0,85


-0,62
-0,57
-8.77%

-0,22

Announcement Date30/03/2311/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread



0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread



-1,26
-1,30
2.83%
-1,76
-1,50
-17.08%

-2,10


-2,90


-3,40

EBIT
Million USD
Released
Forecast
Spread



-1,26
-1,26
-0.26%
-1,76
-1,43
-22.77%

-1,78


-2,30


-2,60

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-1,14
-1,17
2.3%
-1,66
-1,32
-26.49%

-1,70


-2,22


-1,80

Net income
Million USD
Released
Forecast
Spread
-1,04


-1,14
-1,17
2.3%
-1,66
-1,32
-26.49%

-1,70


-2,22


-1,80

EPS
USD
Released
Forecast
Spread
-0,07


-0,05
-0,08
37.5%
-0,10
-0,05
-100%

-0,05


-0,06


-0,07

Announcement Date09/11/2311/03/2409/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Calendar Cadrenal Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW